DIA Singapore Annual Meeting 2025

The DIA Singapore Annual Meeting is a leading conference that brings together professionals from across the healthcare, pharmaceutical, biotechnology, and regulatory sectors in Asia and beyond. The event focuses on the latest trends, innovations, and challenges in drug development, clinical research, regulatory science, and healthcare innovation specific to the Asian region. It provides a platform for networking, knowledge sharing, and collaboration among industry experts, regulators, and technology providers to advance the development and delivery of safe and effective medical products.

Reasons to Attend

• Stay Ahead of APAC Regulatory Trends
  Get the latest updates from regional authorities and uncover strategies to navigate evolving compliance landscapes in Asia.

• Connect with Industry & Regulatory Leaders
  Engage directly with experts from pharma, biotech, medical devices, and regulatory agencies across the region.

• Explore Innovation in Drug Development
  Discover how AI, digital health, and decentralized trials are transforming regulatory science and accelerating market access.

DIA Singapore Annual Meeting 2025 Programme

The DIA Singapore Annual Meeting 2025 will feature expert-led sessions on regulatory transformation, digital innovation in drug development, and clinical trial modernization across Asia, with focused discussions on regulatory convergence, multiregional trials, and collaboration between industry and health authorities.

Navigating the Evolving Healthcare Landscape and Trends in Asia

The DIA Singapore Annual Meeting 2025 will take place July 15–16, 2025, at One Farrer Hotel, Singapore. With sessions focused on digital transformation, regulatory convergence, and multiregional clinical trials, the event highlights how innovation is shaping the future of drug development and compliance. Join a global network of experts committed to advancing regulatory science and accelerating access to safe, effective medical products.